Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 76

1.

Early outcomes after intrathecal baclofen therapy in ambulatory patients with multiple sclerosis.

Lee BS, Jones J, Lang M, Achey R, Dai L, Lobel DA, Nagel SJ, Machado AG, Bethoux F.

J Neurosurg. 2017 Dec 1:1-7. doi: 10.3171/2017.5.JNS162925. [Epub ahead of print]

PMID:
29192855
2.

Editorial.

Bethoux F.

Int J MS Care. 2017 Sep-Oct;19(5):vi. doi: 10.7224/1537-2073-19.5.vi. No abstract available.

3.

Editorial.

Bethoux F.

Int J MS Care. 2017 Jul-Aug;19(4):viii. doi: 10.7224/1537-2073-19.4.viii. No abstract available.

4.

Editorial.

Bethoux F.

Int J MS Care. 2017 May-Jun;19(3):viii. doi: 10.7224/1537-2073-19.3.viii. No abstract available.

5.

Editorial.

Bethoux F.

Int J MS Care. 2017 Jan-Feb;19(1):iv. doi: 10.7224/1537-2073-19.1.iv. No abstract available.

6.

Safety, Tolerability, and Sensorimotor Effects of Extended-release Dalfampridine in Adults With Cerebral Palsy: A Pilot Study.

Bethoux F, Fatemi A, Fowler E, Marciniak C, Mayadev A, Waksman J, Zackowski K, Suarez G, Blight AR, Rabinowicz AL, Carrazana E.

Clin Ther. 2017 Feb;39(2):337-346. doi: 10.1016/j.clinthera.2016.12.015. Epub 2017 Jan 25.

7.

Processing speed test: Validation of a self-administered, iPad®-based tool for screening cognitive dysfunction in a clinic setting.

Rao SM, Losinski G, Mourany L, Schindler D, Mamone B, Reece C, Kemeny D, Narayanan S, Miller DM, Bethoux F, Bermel RA, Rudick R, Alberts J.

Mult Scler. 2017 Dec;23(14):1929-1937. doi: 10.1177/1352458516688955. Epub 2017 Jan 12.

PMID:
28080262
8.

Effects of controlled whole-body vibration training in improving fall risk factors among individuals with multiple sclerosis: A pilot study.

Yang F, Finlayson M, Bethoux F, Su X, Dillon L, Maldonado HM.

Disabil Rehabil. 2016 Dec 15:1-8. doi: 10.1080/09638288.2016.1262466. [Epub ahead of print]

PMID:
27976932
9.

Editorial.

Bethoux F.

Int J MS Care. 2016 Sep-Oct;18(5):vi. No abstract available.

10.

Editorial.

Bethoux F.

Int J MS Care. 2016 Jul-Aug;18(4):iv. doi: 10.7224/1537-2073-18.4.iv. No abstract available.

11.

Editorial.

Bethoux F.

Int J MS Care. 2016 May-Jun;18(3):vi. doi: 10.7224/1537-2073-18.3.vi. No abstract available.

12.
13.

Editorial.

Bethoux F.

Int J MS Care. 2016 Mar-Apr;18(2):iv. doi: 10.7224/1537-2073-18.2.iv. No abstract available.

14.

Correlates of the timed 25 foot walk in a multiple sclerosis outpatient rehabilitation clinic.

Bethoux FA, Palfy DM, Plow MA.

Int J Rehabil Res. 2016 Jun;39(2):134-9. doi: 10.1097/MRR.0000000000000157.

15.

Editorial.

Bethoux F.

Int J MS Care. 2016 Jan-Feb;18(1):iv. doi: 10.7224/1537-2073-18.1.iv. No abstract available.

16.

Editorial.

Bethoux F.

Int J MS Care. 2015 Nov-Dec;17(6):iv. doi: 10.7224/1537-2073-17.6.iv. No abstract available.

17.

Effects of Dalfampridine Extended-release Tablets on 6-minute Walk Distance in Patients With Multiple Sclerosis: A Post Hoc Analysis of a Double-blind, Placebo-controlled Trial.

Applebee A, Goodman AD, Mayadev AS, Bethoux F, Goldman MD, Klingler M, Blight AR, Carrazana EJ.

Clin Ther. 2015 Dec 1;37(12):2780-7. doi: 10.1016/j.clinthera.2015.10.014. Epub 2015 Nov 10.

18.

Spasticity Management After Stroke.

Bethoux F.

Phys Med Rehabil Clin N Am. 2015 Nov;26(4):625-39. doi: 10.1016/j.pmr.2015.07.003. Epub 2015 Sep 26. Review.

PMID:
26522902
19.

Editorial.

Bethoux F.

Int J MS Care. 2015 Sep-Oct;17(5):iv. doi: 10.7224/1537-2073-17.5.iv. No abstract available.

20.

Editorial.

Bethoux F.

Int J MS Care. 2015 Jul-Aug;17(4):iv. doi: 10.7224/1537-2073-17.4.iv. No abstract available.

Supplemental Content

Loading ...
Support Center